|
Jan 6
|
Amicus Therapeutics Inc President and CEO Bradley Campbell Sells 15,833 Shares
|
|
Jan 3
|
15 Best Growth Stocks to Buy Under $25
|
|
Jan 3
|
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 30
|
Even after rising 4.3% this past week, Amicus Therapeutics (NASDAQ:FOLD) shareholders are still down 39% over the past three years
|
|
Dec 29
|
Amicus (FOLD) Banks on Galafold, Overdependence a Concern
|
|
Dec 29
|
Amicus Therapeutics Inc Chief Accounting Officer Sells Company Shares
|
|
Dec 24
|
‘Time to Pull the Trigger,’ Says Morgan Stanley About These 2 Healthcare Stocks
|
|
Dec 21
|
Amicus Therapeutics Inc's Chief Development Officer Sells Shares
|
|
Dec 8
|
Why Is Amicus Therapeutics (FOLD) Up 15% Since Last Earnings Report?
|
|
Dec 5
|
BIO names longtime Amicus head John Crowley as its new CEO
|
|
Dec 5
|
Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO
|
|
Dec 5
|
He Designed Drugs to Save His Children. Now He’s Working to Save Biotech, Too.
|
|
Sep 7
|
Why Is Amicus Therapeutics (FOLD) Down 6.8% Since Last Earnings Report?
|
|
Aug 21
|
Amicus Therapeutics Appoints Simon Harford as Chief Financial Officer
|